Navigation Links
Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA

GAITHERSBURG, Md. and CARLSBAD, Calif., April 18, 2007 /PRNewswire-FirstCall/ -- Micromet, Inc. and MedImmune, Inc. today announced data from a preclinical study in which BiTE(R) molecules targeting carcinoembryonal antigen (CEA) were shown to prevent subcutaneous tumor growth and formation of lung metastases. An established marker for tumor progression, CEA is frequently expressed on breast, colon and other human carcinomas. These data, presented yesterday in a poster session at the 2007 Annual Meeting of the American Association for Cancer Research (AACR), augment a growing body of preclinical and clinical research about the potential anti-cancer activity of BiTE molecules.

BiTE molecules represent a novel class of drugs that function as bi- specific T-cell engagers. They are unique in their ability to enable the body's killer T cells to recognize and attack tumor and target cells, leaving normal cells unharmed. In addition to demonstrating in vitro and in vivo anti- tumor activity, certain CEA-specific BiTE molecules also showed resistance to inhibition by soluble CEA. Because a soluble form of CEA is released from the surface of normal and tumor cells into the bloodstream, BiTE molecules targeting the antigen must not be inhibited by soluble CEA.

"In a joint effort, researchers at Micromet and MedImmune have developed CEA BiTE molecules that appear to be highly potent and to ignore levels of soluble CEA present in cancer patients while continuing to destroy tumor cells," said Patrick Baeuerle, Ph.D., Chief Scientific Officer at Micromet.

CEA is the second target in the research collaboration between Micromet and MedImmune against which new BiTE molecules were successfully generated and tested. The first target is the tyrosine kinase receptor EphA2, which is frequently overexpressed on a wide variety of solid tumors. Research published April 15, 2007 in Cancer Research demonstrated that
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
4. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
5. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
6. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
7. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
8. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
9. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
10. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
11. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR

Post Your Comments:
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.coman...scatalogue. ,, SterilizationSystems&Equipm...eportlinker.com/p0164340/Sterilization-Systems--Eq...rce=prnewswire&utm_medium=pr&utm_campaign=...bethemostimportantandwidelyusedprocedure.Steamster...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.coman...scatalogue. ,, AnesthesiaDisposables-AWorldMar...64276/Anesthesia-Disposables---A-World-Market-Revi...p;utm_campaign=prnewswire ,, Globalgenerala...greeofsaturation.Despitetheconsiderablerisewitness...
(Date:11/23/2009)..., BELLEVUE,Wash.,Nov.23/PRNewswire/--LightScienc...arSeddigh,ChairmanoftheBoard,Elekta,toanewlycreate...forguidingnumerousmedical-productcompanies,includi...ofAkbarSeddighbringsadditionalstrengthinbusinessde...ffHimawan."Mr.Seddighisaworldleaderincancer-therap...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Wine 26 Latin Food 3A They Said It Would Never Last 50814 1Wine 26 Latin Food 3A They Said It Would Never Last 50814 2Team Sports Cant Compete With Films to Keep Kids From Smoking 50812 1Team Sports Cant Compete With Films to Keep Kids From Smoking 50812 2Team Sports Cant Compete With Films to Keep Kids From Smoking 50812 3Students with depression twice as likely to drop out of college 50810 1Students with depression twice as likely to drop out of college 50810 2
...ELAIDE and COPENHAGEN, Feb. 19 Bionomics,Limited ...essful completion,of pre-clinical testing on the f... Danish antibody company Genmab A/S (OMX: GEN), tr...r the agreement, which was executed in February 20... to eight proteins identified and,characterised by...
...APEL HILL, N.C., Feb. 15 The landscape of scienti...s changing with the advent of,transparency guideli...located in the marketing function, but publication...rease clinical presentation, according to a new,re...marking study that included such influential compa...
Other Medicine Technology:Bionomics Achieves US$1 Million Milestone Payment from Genmab 2Bionomics Achieves US$1 Million Milestone Payment from Genmab 3Industry Executives Finding Value in Shift of Scientific Publications 2
(Date:11/23/2009)...ewswire/--Howistheeconomyaffectingpeople,swellness...ssonWellness&theEconomy,theeconomyismakingusco...ifestyleofexerciseanddiettoonethatismoreinwardlyfo...urvey,smostdramaticfindingwasthechangeinconsumers,...ocusonhealthandwellbeingtotoday,smorerelevantconce...
(Date:11/23/2009)...air breathing, protein may be the cause , ...archers say they,ve identified a protein that cau...rcent of people with chronic sinusitis. , The c...itis, a constant irritation and swelling of the na...nus tissue -- can block the sinus passages and mak...
(Date:11/23/2009)...osure shortly after birth to ambient metals from r...om diesel emissions are associated with respirator... to a new study by researchers at the Columbia Cen... Columbia University,s Mailman School of Public He...ts of exposure to airborne metals in this very you...
(Date:11/23/2009)...aduate student Jennifer Heys wants to make her mes...andan communities about contraception. , Heys, ...sire to bear more children, was read by experts fr...e International Conference on Family Planning in K...l of Public Health, spent six months interviewing ...
(Date:11/23/2009)...Plastic and Reconstructive Surgery...In Brief is d...d on the most current journal news from the Americ...he full studies highlighted here, or to arrange an...S Public Relations at (847) 228-9900 or media@plas... November 23, 2009 -- Yes, Plastic Surgeons Have P...
Breaking Medicine News(10 mins):Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3
...RY TOWNSHIP, Pa., Jan. 14 Three Rivers,Pharmaceut...C drug Infergen,from Valeant Pharmaceuticals Inter...illion from Three Rivers for the procurement., "A...chase is only a beginning for Three Rivers, contin...
...LPHIA, Jan. 14 A new prospective study of pain,in...pain is far more,prevalent and severe than previou...tudy gave diaries to 232 sickle cell disease patie...kle,cell pain assumed that if patients didn,t go t...
...nia to Join Nationwide Campaign Challenging U.S. t...er Care, Survival, SACRAMENTO, Calif., Jan. 14 O...en California Affiliates of Susan G. Komen,for the...t cancer care that cause some women to die of the ...
... drug comes with serious risks, FDA notes , ... controversial drug used to treat multiple scleros...to severe form of another autoimmune illness, Croh...ain infection, as well as other side effects, so i...
...ADELPHIA Anyone can save a life. Thats the messag...a School of Medicine. , Benjamin S. Abella, MD, ...for Resuscitation Science and Assistant Professor ... arrests that occur each year outside of hospitals...
...quality in the UK has improved significantly over ...by the National Physical Laboratory (NPL). Monitor... in the presence of harmful heavy metals such as l...otal average concentration has fallen from 1873 na...
Other Medicine News:Health News:Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals 2Health News:Sickle Cell Disease Pain Can Occur Daily and Is Much More Severe Than Previously Thought 2Health News:California Affiliates of Susan G. Komen for the Cure Convene Celebrities, Breast Cancer Survivors and Activists to Challenge Elected Officials to Strengthen Breast Cancer Services 2Health News:California Affiliates of Susan G. Komen for the Cure Convene Celebrities, Breast Cancer Survivors and Activists to Challenge Elected Officials to Strengthen Breast Cancer Services 3Health News:MS Drug Tysabri Approved for Crohn's Disease 2Health News:MS Drug Tysabri Approved for Crohn's Disease 3Health News:Anyone can save a life: Penn researchers lead national efforts to improve CPR quality 2Health News:Anyone can save a life: Penn researchers lead national efforts to improve CPR quality 3Health News:Heavy metal slips down UK air quality charts 2
STA Compact CT
...afollicular C-cells of the thyroid gland and is pa...calcitonin is to lower plasma calcium concentratio...n decreased mobilization of calcium from bone [1]....ted with high levels of bone remodeling (e.g. in P...
...protein, which is produced primarily during fetal ...etal serum AFP levels peak at ~14 weeks gestation,...-gestation (14-20 weeks). Although production rat...crease after mid-gestation, a gradual decline in b...
...s a two chain (alpha- and beta-subunits) glycoprot...e placenta and is normally found in urine and bloo...epithelium of the placenta, hCG acts to maintain t... The primary utility of hCG measurement is for the...
Medicine Products: